UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes

Molecular neurobiology, 2012-08, Vol.46 (1), p.194-204

2012

Volltextzugriff (PDF)

Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer's Disease—Therapeutic Aspects

Molecular neurobiology, 2010-06, Vol.41 (2-3), p.159-171

2010

Volltextzugriff (PDF)

Lavender oil preparation Silexan is effective in generalized anxiety disorder – a randomized, double-blind comparison to placebo and paroxetine

The international journal of neuropsychopharmacology, 2014-06, Vol.17 (6), p.859-869

2014

Volltextzugriff (PDF)

Mitochondrial Dysfunction as a Causative Factor in Alzheimer's Disease-Spectrum Disorders: Lymphocytes as a Window to the Brain

Current Alzheimer research, 2021-01, Vol.18 (10), p.733-752

2021

Volltextzugriff (PDF)

A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam

Journal of Alzheimer's disease, 2016-01, Vol.50 (1), p.201-215

2016

Volltextzugriff (PDF)

Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients

Neurobiology of disease, 2009-08, Vol.35 (2), p.251-257

2009

Volltextzugriff (PDF)

Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea

Journal of Neural Transmission, 2024-03, Vol.131 (3), p.203-212

2024

Volltextzugriff (PDF)

Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis

Journal of neurochemistry, 2014-05, Vol.129 (4), p.559-572

2014

Volltextzugriff (PDF)

Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice

Neuro-degenerative diseases, 2008-01, Vol.5 (3-4), p.157-159

2008

Volltextzugriff (PDF)

Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender

Neurochemistry international, 2021-02, Vol.143, p.104899, Article 104899

2021

Volltextzugriff (PDF)

Simvastatin protects neurons from cytotoxicity by up‐regulating Bcl‐2 mRNA and protein

Journal of neurochemistry, 2007-04, Vol.101 (1), p.77-86

2007

Volltextzugriff (PDF)

Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam

Frontiers in neuroscience, 2010-01, Vol.4

2010

Volltextzugriff (PDF)

Modulation of Cholesterol, Farnesylpyrophosphate, and Geranylgeranylpyrophosphate in Neuroblastoma SH-SY5Y-APP695 Cells: Impact on Amyloid Beta-Protein Production

Molecular neurobiology, 2010-06, Vol.41 (2-3), p.341-350

2010

Volltextzugriff (PDF)

From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer’s Disease

Molecular neurobiology, 2012-08, Vol.46 (1), p.186-193

2012

Volltextzugriff (PDF)

Statins and neuroprotection: a prescription to move the field forward

Annals of the New York Academy of Sciences, 2010-06, Vol.1199 (1), p.69-76

2010

Volltextzugriff (PDF)

Mitochondrial Function, Dynamics, and Permeability Transition: A Complex Love Triangle as A Possible Target for the Treatment of Brain Aging and Alzheimer's Disease

Journal of Alzheimer's disease, 2018-01, Vol.64 (s1), p.S455-S467

2018

Volltextzugriff (PDF)

TRPC6 channel‐mediated neurite outgrowth in PC12 cells and hippocampal neurons involves activation of RAS/MEK/ERK, PI3K, and CAMKIV signaling

Journal of neurochemistry, 2013-11, Vol.127 (3), p.303-313

2013

Volltextzugriff (PDF)

A New Link to Mitochondrial Impairment in Tauopathies

Molecular neurobiology, 2012-08, Vol.46 (1), p.205-216

2012

Volltextzugriff (PDF)

Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8

Neurochemistry international, 2013-04, Vol.62 (5), p.595-602

2013

Volltextzugriff (PDF)

Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function

Neural plasticity, 2016-01, Vol.2016 (2016), p.1-14

2016

Volltextzugriff (PDF)

No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial

The international journal of neuropsychopharmacology, 2021-03, Vol.24 (3), p.171-180

2021

Volltextzugriff (PDF)

A cell model for the initial phase of sporadic Alzheimer's disease

Journal of Alzheimer's disease, 2014-01, Vol.42 (2), p.395-411

2014

Volltextzugriff (PDF)

Editorial: Siegfried Hoyer’s concept of Alzheimer pathophysiology

Journal of Neural Transmission, 2015-04, Vol.122 (4), p.495-497

2015

Volltextzugriff (PDF)

Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice

Neurobiology of disease, 2005-02, Vol.18 (1), p.89-99

2005

Volltextzugriff (PDF)

Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment

Neurobiology of disease, 2007-02, Vol.25 (2), p.438-445

2007

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences & Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(96)

Sprache

Englisch
(95)
Japanisch
(14)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes

Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer's Disease—Therapeutic Aspects

Lavender oil preparation Silexan is effective in generalized anxiety disorder – a randomized, double-blind comparison to placebo and paroxetine

Mitochondrial Dysfunction as a Causative Factor in Alzheimer's Disease-Spectrum Disorders: Lymphocytes as a Window to the Brain

A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam

Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients

Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea

Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis

Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice

Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender

Simvastatin protects neurons from cytotoxicity by up‐regulating Bcl‐2 mRNA and protein

Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam

Modulation of Cholesterol, Farnesylpyrophosphate, and Geranylgeranylpyrophosphate in Neuroblastoma SH-SY5Y-APP695 Cells: Impact on Amyloid Beta-Protein Production

From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer’s Disease

Statins and neuroprotection: a prescription to move the field forward

Mitochondrial Function, Dynamics, and Permeability Transition: A Complex Love Triangle as A Possible Target for the Treatment of Brain Aging and Alzheimer's Disease

TRPC6 channel‐mediated neurite outgrowth in PC12 cells and hippocampal neurons involves activation of RAS/MEK/ERK, PI3K, and CAMKIV signaling

A New Link to Mitochondrial Impairment in Tauopathies

Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8

Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function

No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial

A cell model for the initial phase of sporadic Alzheimer's disease

Editorial: Siegfried Hoyer’s concept of Alzheimer pathophysiology

Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice

Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment

Aktive Filter

Suchergebnisse filtern